Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oncology Pharmaceutical Market in China: The Year of the Crab

This article was originally published in Start Up

Executive Summary

Cancer has overtaken respiratory and infectious diseases as the leading cause of mortality in both urban and rural China, creating an enormous demand for anti-cancer pharmaceuticals. According to "China Anti-Cancer Drug Market", a report distributed by FDC-Windhover Elsevier, the sales growth of anti-cancer drugs in China spiked from 11.1% in 2006 to 25.4% in 2007, at which point the market was worth $3.5 billion.

Related Content

China: The Wild, Wild East for Medical Devices
China: The Asian Dragon Lures Foreign Investors





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts